Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study

LESSONS LEARNED: Cisplatin/tegafur/uracil/irinotecan triple combination therapy shows moderate response, especially in patients without previous chemoradiotherapy within the 6 months before this combination therapy. Toxicity is tolerable, and quality of life is improved in responders. BACKGROUND. Th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Chen, San-Chi, Chang, Peter Mu-Hsin, Yang, Muh-Hwa
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2016
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4861372/
https://ncbi.nlm.nih.gov/pubmed/27091418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0515
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires